Summary by Moomoo AI
Pharmaceutical United Biotechnology Co., Ltd. (WuXi XDC Cayman Inc.) , filed with Hong Kong Trading and Settlement Limited on 5 January 2024 with the Securities Monthly Change Report for the year ended 31 December 2023. The report showed that the company's regulated/registered share capital remained at 10,000,000,000 shares with a face value of $0.00005 per share for a total of $500,000, unchanged this month. In addition, the Company issued and distributed 19,158,500 shares of ordinary shares on December 13, 2023 pursuant to the reports. Details were disclosed in the Announcement dated December 10, 2023 and the Disclosure Report on the following day. In terms of stock options, the Company issued multiple share options under the share option plan in 2023, but no new shares were issued during this month as a result of the exercise of options. The report also confirms that all securities issued have been formally authorised by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.